Literature DB >> 17320979

Development of a new neutralization test for measles virus.

Motoko Fujino1, Naoko Yoshida, Keiko Kimura, Jianhui Zhou, Yoshie Motegi, Katsuhiro Komase, Tetsuo Nakayama.   

Abstract

Sero-epidemiological studies are required to identify populations susceptible to measles. The hemagglutination inhibition (HI) test is no longer sensitive enough to confirm immunity to measles, and at present the particle agglutination (PA) test and enzyme-linked immunosorbent assay (EIA) are employed. The most reliable method is the neutralization test (NT), but it is time-consuming and requires experience. To simplify the NT, a recombinant measles AIK-C virus expressing green fluorescence protein (GFP-MVAIK) was constructed and used as a challenge virus. Plaques and cytopathic effects were visualized under ultraviolet light and detected easily, and measuring the intensity of the fluorescence enabled a reduction in the time-consuming steps. Neutralizing antibody titers of a complete inhibition neutralization test were equivalent to those of a 90% plaque reduction neutralization test. Comparison of four methods, HI, PA, EIA and the complete inhibition neutralization test, showed that only the results of EIA correlated well with those of the complete inhibition neutralization test, but sera with borderline levels by EIA were sometimes negative by the complete inhibition neutralization assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320979     DOI: 10.1016/j.jviromet.2007.01.001

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  HIV-1 infection ex vivo accelerates measles virus infection by upregulating signaling lymphocytic activation molecule (SLAM) in CD4+ T cells.

Authors:  Yu-ya Mitsuki; Kazutaka Terahara; Kentaro Shibusawa; Takuya Yamamoto; Takatsugu Tsuchiya; Fuminori Mizukoshi; Masayuki Ishige; Seiji Okada; Kazuo Kobayashi; Yuko Morikawa; Tetsuo Nakayama; Makoto Takeda; Yusuke Yanagi; Yasuko Tsunetsugu-Yokota
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

Review 3.  Fluorescent and Bioluminescent Reporter Myxoviruses.

Authors:  Christina A Rostad; Michael C Currier; Martin L Moore
Journal:  Viruses       Date:  2016-08-04       Impact factor: 5.048

4.  Development of a high-throughput assay to measure measles neutralizing antibodies.

Authors:  Esmeralda Alvarado-Facundo; Susette Audet; William J Moss; Judy A Beeler
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

5.  Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.

Authors:  Tetsuo Nakayama; Masahiro Eda; Motonori Hirano; Wakako Goto
Journal:  Hum Vaccin Immunother       Date:  2019-04-22       Impact factor: 3.452

6.  Study on the Antiviral Activities and Hemagglutinin-Based Molecular Mechanism of Novel Chlorogenin 3-O-β-Chacotrioside Derivatives Against H5N1 Subtype Viruses.

Authors:  Wan-Zhen Shi; Ling-Zhi Jiang; Gao-Peng Song; Sheng Wang; Ping Xiong; Chang-Wen Ke
Journal:  Viruses       Date:  2020-03-11       Impact factor: 5.048

7.  Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.

Authors:  Iana H Haralambieva; Whitney L Simon; Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Warner; Diane E Grill; Gregory A Poland
Journal:  Viruses       Date:  2015-03-10       Impact factor: 5.048

8.  Sensitive detection of measles virus infection in the blood and tissues of humanized mouse by one-step quantitative RT-PCR.

Authors:  Shota Ikeno; Moto-Omi Suzuki; Mahmod Muhsen; Masayuki Ishige; Mie Kobayashi-Ishihara; Shinji Ohno; Makoto Takeda; Tetsuo Nakayama; Yuko Morikawa; Kazutaka Terahara; Seiji Okada; Haruko Takeyama; Yasuko Tsunetsugu-Yokota
Journal:  Front Microbiol       Date:  2013-10-11       Impact factor: 5.640

9.  A new method for the detection of neutralizing antibodies against mumps virus.

Authors:  Keita Matsubara; Motoko Fujino; Kaoru Takeuchi; Satoshi Iwata; Tetsuo Nakayama
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

10.  Dual Promoters Improve the Rescue of Recombinant Measles Virus in Human Cells.

Authors:  Soroth Chey; Juliane Maria Palmer; Laura Doerr; Uwe Gerd Liebert
Journal:  Viruses       Date:  2021-08-30       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.